H3N2 Influenza-A Virus Brisbane 10/07, H3N2 Brisbane, 50ug

CAT No.BT-IHA-024

H3N2 Influenza-A Virus Brisbane 10/07, H3N2 Brisbane, 50ug

---

Description
Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Brisbane/10/07. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient.

Immunological Activity
Tested with anti-influenza A monoclonal antibodies in ELISA.
Serological studies of influenza A virus, immunogen for antibody production.

Inactivation
Thimerosal and beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.

Sterile Filtered colorless solution FormulationThe H3N2 A/Brisbane/10/07 solution contains STE, 0.1 % sodium azide (NaN3) and 0.005 % thimerosal.

Purity
Greater than 90.0% as determined byAnalysis by SDS-PAGE.

Stability
A/Brisbane/10/07 although stable 4¡ãC for 4 weeks, should be stored desiccated below -18¡ãC.
Please prevent freeze-thaw cycles.

Usage
TSZGENE's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.

Description
Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Malaysia/2506/04. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient.